Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10849860 Use of cannabinoids in the treatment of epilepsy

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
November 21, 2018
Date of Patent
December 1, 2020
Patent Application Number
16198141
Patent Citations Received
‌
US Patent 12121617 Transdermal delivery of cannabidiol
0
‌
US Patent 12016829 Pharmaceutical composition and method for treating seizure disorders
0
‌
US Patent 12023346 Compositions and methods for treating epilepsy
0
‌
US Patent 12102619 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
0
‌
US Patent 10966939 Use of cannabinoids in the treatment of epilepsy
‌
US Patent 11590087 Cannabidiol-type cannabinoid compound
‌
US Patent 11633369 Use of cannabinoids in the treatment of epilepsy
0
‌
US Patent 11684598 Use of cannabinoids in the treatment of epilepsy
0
‌
US Patent 11701330 Use of cannabinoids in the treatment of epilepsy
0
‌
US Patent 11311498 Use of cannabinoids in the treatment of epilepsy
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10849860
Patent Primary Examiner
‌
Kortney L. Klinkel

Find more entities like US Patent 10849860 Use of cannabinoids in the treatment of epilepsy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.